Browse the evidence

In states of fatty acid overload (obesity, diabetes), intramyocardial triglyceride accumulation acts as a cytoprotective buffer that prevents lipotoxicity and cardiac damage; however, once this storage capacity is exhausted, toxic lipid intermediates accumulate, leading to dysfunction.

If you have metabolic issues, your heart stores fat to protect itself from toxic fatty acids. Simply trying to reduce heart fat without fixing the underlying metabolic overload (via diet/exercise) might remove this protective buffer and worsen heart health. Focus on reducing fatty acid overload rather than just fat mass.

Epicardial and perivascular fat act as a protective vasocrine organ in healthy states by releasing adiponectin and relaxing factors, but in metabolic disease, their expansion leads to hypoxia, inflammation, and a shift toward prothrombotic and proinflammatory signaling that promotes atherosclerosis.

Fat around your heart is not just inert storage; it actively communicates with your arteries. In metabolic disease, this fat becomes inflamed and harmful. Weight loss and exercise can reduce this fat and its inflammatory output, improving vascular health.

Increasing carbohydrate availability (via glucose ingestion or high glycogen stores) reciprocally downregulates fat oxidation in skeletal muscle during exercise through insulin-mediated suppression of adipose lipolysis and direct inhibition of fatty acid transport proteins.

When you eat carbohydrates before or during exercise, your body prioritizes burning those carbs and burns less fat. This happens because insulin rises (blocking fat release from storage) and transport proteins for fat are inhibited. To maximize fat oxidation during exercise, you would need to exercise in a fasted state or avoid carbohydrate intake, but this comes at the cost of performance and glycogen sparing.

Increasing exercise intensity above approximately 75% VO2max downregulates fat oxidation due to decreased adipose blood flow, reduced FFA delivery, and intramuscular inhibition of fatty acid transport and oxidation.

If your goal is to maximize the amount of fat you burn *during* your workout, keep your intensity moderate (around 60-65% of your max oxygen uptake). If you exercise at very high intensities (above 75% VO2max), your body switches to burning mostly carbohydrates because it can't deliver and process fat fast enough to meet the energy demand.

Increasing fat availability (via elevated plasma free fatty acids) downregulates carbohydrate oxidation in skeletal muscle during exercise, primarily by inhibiting glycogen phosphorylase (PHOS) activity through reduced accumulation of ADP and AMP.

If you consume a high-fat meal or supplement before exercise, your body will burn more fat and less glycogen. However, this 'fat sparing' effect does not necessarily improve performance. For optimal performance, especially at high intensities, relying on carbohydrates is still superior.

Caloric Restriction (CR) extends lifespan and mitigates aging biomarkers primarily by inhibiting mTORC1 signaling, thereby inducing autophagy, rather than solely through antioxidant effects.

You don't need to starve yourself. The paper suggests that 'amino acid-restriction' alone can trigger the CR response. Focus on reducing overall caloric intake or specific amino acids (like methionine/leucine) periodically to activate mTOR inhibition and autophagy, rather than just eating 'healthy' without regard to quantity.

In community-dwelling adults aged 80+, the Short Physical Performance Battery (SPPB) score and Self-Rated Health (SRH) status are independent, significant predictors of all-cause mortality, with the SPPB chair stand subtask being the strongest physical predictor.

For adults over 80, getting a Short Physical Performance Battery (SPPB) test and honestly assessing your general health status are powerful ways to predict longevity risk. The chair stand test (standing up from a chair 5 times) is a key component of the SPPB and is as useful as the full battery for predicting mortality. You do not need to combine these with other complex tests for better prediction; focusing on these simple metrics is sufficient.

Macrophage-secreted factors induce a profibrotic phenotype in human preadipocytes, characterized by increased proliferation, migration, and synthesis of extracellular matrix (ECM) proteins like fibronectin and collagen I.

Chronic obesity creates an inflammatory environment in fat tissue where immune cells signal fat precursor cells to become fibrotic and proliferative. This biological change makes fat tissue more resistant to change. Addressing obesity may require strategies that reduce inflammation, not just caloric restriction.

Inhibin A, secreted by macrophages or induced in preadipocytes, is a major profibrotic factor driving the synthesis of fibronectin and collagen I.

Inhibin A is identified as a specific protein that drives fat tissue scarring. This highlights a potential target for future therapies to reverse obesity-related fibrosis.

The fibronectin/integrin alpha5 partnership is essential for the proliferation of inflammatory preadipocytes.

Blocking the interaction between fibronectin and integrin alpha5 can stop the proliferation of fat precursor cells in a fibrotic environment.

NF-kappaB and Cyclin D1 are critical molecular links connecting inflammation, ECM remodeling, and preadipocyte proliferation.

Targeting NF-kappaB or Cyclin D1 pathways could potentially disrupt the cycle of inflammation and fibrosis in fat tissue.

Obesity induces a chronic low-grade inflammatory state characterized by macrophage infiltration and elevated proinflammatory cytokines (TNF-α, IL-6, IL-1β), which promotes cancer development through NF-κB activation and growth factor signaling.

Maintaining a healthy weight helps reduce chronic inflammation, which is a known biological driver of cancer risk. While weight management is complex, reducing excess adipose tissue can lower the levels of proinflammatory cytokines and hormones that promote tumor growth.

Calorie restriction (20-40% reduction) inhibits carcinogenesis by modulating metabolic hormones (IGF-1, insulin, leptin, adiponectin) and decreasing inflammatory cytokine production.

Reducing calorie intake by 20-40% can lower cancer risk by improving hormone balance and reducing inflammation. If strict CR is too difficult, researchers are exploring drugs and natural products (like metformin or resveratrol) that might mimic these benefits.

Adiponectin levels are inversely correlated with adiposity and exert anticancer effects by decreasing insulin/IGF-1 signaling and reducing proinflammatory cytokine expression.

Higher levels of adiponectin, which are typically found in leaner individuals, are associated with lower cancer risk. This hormone helps regulate glucose metabolism and reduces inflammation.

High luminal glucose concentrations trigger the translocation of the facilitative transporter GLUT2 to the brush border membrane (BBM) of enterocytes, thereby increasing the capacity for D-glucose absorption.

Your small intestine is designed to absorb glucose more efficiently when you consume a high-glucose meal. It does this by moving specific transporters (GLUT2) to the surface of the cells facing the gut lumen. This is a normal, healthy physiological response to maximize nutrient uptake from carbohydrate-rich foods.

SGLT1 abundance in the brush border membrane increases in response to high luminal glucose, mediating high-capacity glucose absorption.

When you eat foods high in glucose, your body increases the number of SGLT1 transporters on the surface of your intestinal cells. This allows your body to absorb more glucose efficiently from your meal.

GLUT5 is the primary facilitative transporter responsible for D-fructose absorption in the small intestine.

Your body uses a specific transporter called GLUT5 to absorb fructose (fruit sugar) from your small intestine. This is a dedicated pathway distinct from the primary glucose absorption mechanisms.

Moderate fish consumption (up to 5+ meals/week) does not reduce the risk of myocardial infarction, stroke, or cardiovascular death in middle-aged to older men.

If you are a healthy man, eating fish several times a week is unlikely to lower your risk of heart attack or stroke based on this 4-year study. While fish is a healthy food, relying on it as a primary strategy to prevent cardiovascular disease is not supported by this evidence. Focus on proven risk factor management (blood pressure, cholesterol, smoking) rather than expecting fish to act as a shield.

Being a definite evening chronotype is associated with a significantly increased risk of all-cause mortality compared to being a definite morning type, even after adjusting for age, sex, BMI, smoking, and comorbidities.

If you are a definite evening type, be aware that your natural schedule may carry a slightly higher mortality risk, largely due to misalignment with societal norms. You can mitigate this by prioritizing morning light exposure, avoiding late-night artificial light, and ensuring your diet and sleep habits are optimized. Consider advocating for flexible work hours if possible.

In older adults, age-related sarcopenia is mechanistically driven by increased SOCS-3 and myostatin levels, which inhibit Akt phosphorylation efficiency, leading to reduced muscle protein synthesis and fiber atrophy.

As you age, your body naturally increases signals (SOCS-3 and myostatin) that block muscle growth pathways. To combat this, you must actively stimulate muscle protein synthesis through resistance training and adequate protein intake to override these inhibitory signals, as passive aging leads to significant muscle fiber shrinkage.

In humans, changes in plasma leptin concentrations resulting from weight loss or gain do not correlate with changes in energy expenditure, suggesting leptin is not the primary signal mediating metabolic adaptation to altered body weight.

Your body's metabolic slowdown during weight loss is not primarily driven by leptin levels. While leptin does drop when you lose fat, this drop doesn't predict how much your metabolism will slow down. Focusing on leptin as the 'cause' of metabolic adaptation is likely a distraction from other physiological mechanisms.

Roux-en-Y gastric bypass (RYGB) increases postprandial GLP-1 and decreases TSH, whereas Laparoscopic Adjustable Gastric Banding (LAGB) does not, despite both causing similar weight loss.

RYGB surgery changes your gut hormone (GLP-1) and thyroid hormone (TSH) levels more than LAGB does, even if you lose the same amount of weight. This suggests the surgery itself, not just the weight loss, affects how your body regulates energy and appetite.

Skeletal muscle-derived myokines (Irisin, Cathepsin B) and metabolites (Lactate, β-Hydroxybutyrate, Kynurenic Acid) mediate exercise-induced neuroprotection, angiogenesis, and memory enhancement via blood-brain barrier signaling.

Regular physical activity sends chemical signals from your muscles to your brain that protect neurons, improve memory, and boost mood. You don't need to know the specific molecules; consistent exercise is the key to activating this muscle-to-brain communication system.

Exercise-induced elevation of muscle PGC-1α shifts kynurenine metabolism toward kynurenic acid, reducing neurotoxic kynurenine accumulation and conferring resistance to stress-induced depression.

For those struggling with stress or depression, regular endurance exercise helps your muscles process tryptophan in a way that prevents neurotoxic buildup in the brain. This biological mechanism offers protection against stress-induced mood disorders.